Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
← catalyst calendarNCT07215767 · readout ≤ 11 d
Sponsored by HALEON (industry) · HLN — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
688actual
Sites
3
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-09-16 | actual | When the study began enrolling |
| Primary completion | Aug 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2025-10-10 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Dentin Hypersensitivity
Interventions
- Drug: Stannous fluoride and Potassium nitrate Dentifrice
- Drug: Stannous fluoride Dentifrice
- Drug: Potassium nitrate Dentifrice
- Drug: Vehicle Dentifrice
Primary outcomes
what the primary-completion date above is the date OFChange from Baseline in Schiff sensitivity score at Week 8 (Test Dentifrice Versus [Vs] Reference Dentifrices 1, 2 and 3)
measured Baseline and Week 8
Change from Baseline in tactile threshold (grams [g]) at Week 8 (Test Dentifrice Vs Reference Dentifrices 1, 2 and 3)
measured Baseline and Week 8
Permalink · HLN's whole pipeline · Catalyst calendar · Every registered study · What changed